Shares of Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $5.62 and traded as high as $9.00. Hemispherx BioPharma shares last traded at $6.70, with a volume of 7,639 shares trading hands.
Hemispherx BioPharma Price Performance
The company’s 50-day simple moving average is $6.70 and its 200-day simple moving average is $5.66.
About Hemispherx BioPharma
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Featured Articles
- Five stocks we like better than Hemispherx BioPharma
- Airline Stocks – Top Airline Stocks to Buy Now
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- Growth Stocks: What They Are, What They Are Not
- SoFi Technologies: From Fintech Speculation to Profit Engine
- How to start investing in penny stocks
- Gold to $5,000? What Bank of America and UBS Have to Say
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
